Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

May 16, 2022

Study Completion Date

May 25, 2022

Conditions
Lumbosacral Radiculopathy
Interventions
DRUG

ETX-018810

Study Drug

DRUG

Placebo

Placebo

Trial Locations (24)

10530

Drug Trials America, Hartsdale

14618

University of Rochester Translational Pain Research, Rochester

16635

Altoona Center for Clinical Research, Duncansville

27103

Center for Clinical Research, Winston-Salem

29406

Clinical Trials of South Carolina, Charleston

30060

Drug Studies America, Marietta

30265

Better Health Clinical Research, Newnan

32159

Charter Research, Lady Lake

33155

Cordova Research Institute, Miami

33174

Advanced Medical Research Institute, Miami

33186

Coral Research Clinic Corp, Miami

36606

Delta Clinical Research, Mobile

45432

Meta Medical Research Institute, Dayton

46032

Indiana Spine Group, Carmel

60657

Chicago Anesthesia Research Specialist, Chicago

63042

Healthcare Research Network, Hazelwood

73013

Clinical Investigations LLC, Edmond

75701

Precision Spine care, Tyler

80111

DBPS Research LLC, Greenwood Village

83713

Injury Care Research, Boise

84107

Jean Brown Research, Salt Lake City

Wasatch Clinical Research, LLC, Salt Lake City

85053

Arizona Research Center, Phoenix

98007

Northwest Clinical Research center, Bellevue

Sponsors
All Listed Sponsors
lead

Eliem Therapeutics (UK) Ltd.

INDUSTRY